June 5th 2025
Valneva’s immunization, Ixchiq, was well tolerated in children ages 1 to 11 years regardless of the dose or previous chikungunya infection.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
View More
Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice
View More
Symposium Updates Knowledge of Zika Virus and Countermeasures
October 28th 2016Zika has been around for a long time, with the first report dating back to 1947. Until 2007, only 14 cases had been reported. Subsequently, there have been three outbreaks, culminating with its arrival in the Americas in the 2015 epidemic in Brazil.
Read More
Public Turns to Facebook for Zika Information, But is it Accurate?
October 26th 2016With social media serving as a news source to so many, researchers from the Medical College of Wisconsin and the Tulane University School of Medicine studied how Facebook users are talking about the Zika virus.
Read More
Can I Administer the Influenza Vaccine to a Patient with Zika?
October 21st 2016Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses if the influenza vaccine can be administered to a patient with Zika.
Watch
Researchers Discover Effective Vaccine Program for Dengue-Affected Countries
October 20th 2016Researchers at Sanofi Pasteur, have developed a “transmission model” for Dengue and assessed the population impact of vaccination in the 10 countries participating in the Phase III efficacy studies for CYD-TDV/Dengvaxia.
Read More
Vertical Transmission of Zika: Should We Be Concerned?
October 19th 2016Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses if vertical transmission of Zika is cause for concern.
Watch